Clínica Universitaria de Navarra -ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2019

  1. Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)

    Scientific Reports

  2. Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

2007

  1. Treatment guidelines in ovarian cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 5, pp. 308-316